We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+5.81%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$32.7B
AUM Growth
+$3.39B
(+12%)
Cap. Flow
+$2.02B
Cap. Flow
% of AUM
6.18%
Top 10 Holdings %
Top 10 Hldgs %
20.34%
Holding
1,273
New
114
Increased
570
Reduced
394
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$437M |
| 2 |
Intuit
INTU
|
+$333M |
| 3 |
Mastercard
MA
|
+$203M |
| 4 |
Booking.com
BKNG
|
+$186M |
| 5 |
Alibaba
BABA
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$290M |
| 2 |
Akamai
AKAM
|
+$278M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$264M |
| 4 |
Cognizant
CTSH
|
+$252M |
| 5 |
Acuity Brands
AYI
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.14% |
| 2 | Financials | 16.99% |
| 3 | Healthcare | 14.67% |
| 4 | Consumer Discretionary | 12.2% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Renasant Corp
RNST
$4B
| $23.9M | 0.07% |
547,434
+3,804
| +0.7% | +$159K |
|
202
DuPont de Nemours
DD
$18.9B
| $23.9M | 0.07% |
149,608
+5,955
| +4% | +$946K |
|
203
Regis Corp
RGS
$72.7M
| $23.9M | 0.07% |
116,235
-54,644
| -32% | -$11.2M |
|
204
Verisk Analytics
VRSK
$25.2B
| $23.7M | 0.07% |
281,047
-108,102
| -28% | -$8.75M |
|
205
Enbridge
ENB
$123B
| $23.4M | 0.07% |
588,691
+770
| +0.1% | +$31K |
|
206
Intel
INTC
$516B
| $23M | 0.07% |
681,762
-59,970
| -8% | -$2.15M |
|
|
CBF
207
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
| $22.9M | 0.07% |
601,009
-791,182
| -57% | -$31.3M |
|
208
Middleby
MIDD
$5.92B
| $22.9M | 0.07% |
188,277
+24,641
| +15% | +$3.25M |
|
209
Clearwater Paper
CLW
$268M
| $22.6M | 0.07% |
483,048
+7,564
| +2% | +$365K |
|
210
Weyerhaeuser
WY
$17.2B
| $22.3M | 0.07% |
666,852
-10,073
| -1% | -$339K |
|
|
DST
211
DELISTED
DST Systems Inc.
DST
| $22.3M | 0.07% |
361,684
-1,080
| -0.3% | -$65.9K |
|
212
Mettler-Toledo International
MTD
$26B
| $22.2M | 0.07% |
37,743
-13,154
| -26% | -$7.21M |
|
213
WEX
WEX
$5.4B
| $22.1M | 0.07% |
212,236
+5,112
| +2% | +$526K |
|
|
STI
214
DELISTED
SunTrust Banks, Inc.
STI
| $21.9M | 0.07% |
385,637
+19,591
| +5% | +$1.09M |
|
215
Vanguard Information Technology ETF
VGT
$142B
| $21.7M | 0.07% |
1,233,048
+49,336
| +4% | +$869K |
|
|
ONC
216
BeOne Medicines Ltd
ONC
$33.2B
| $21.7M | 0.07% |
481,702
+2,351
| +0.5% | +$92.6K |
|
217
Global Payments
GPN
$21.6B
| $21.1M | 0.06% |
234,123
+10,599
| +5% | +$916K |
|
|
CLGX
218
DELISTED
Corelogic, Inc.
CLGX
| $21.1M | 0.06% |
486,479
+52,604
| +12% | +$2.22M |
|
219
Dover
DOV
$28.9B
| $21.1M | 0.06% |
325,388
-22,923
| -7% | -$1.49M |
|
220
Vanguard FTSE Emerging Markets ETF
VWO
$121B
| $21M | 0.06% |
513,705
+77,693
| +18% | +$3.15M |
|
221
Vanguard Extended Market ETF
VXF
$30.5B
| $21M | 0.06% |
205,040
+32,808
| +19% | +$3.31M |
|
222
Illinois Tool Works
ITW
$78.8B
| $20.9M | 0.06% |
145,950
+418
| +0.3% | +$58.3K |
|
|
MON
223
DELISTED
Monsanto Co
MON
| $20.6M | 0.06% |
174,015
-2,806
| -2% | -$327K |
|
224
Becton Dickinson
BDX
$42.2B
| $20.5M | 0.06% |
107,879
+1,977
| +2% | +$361K |
|
|
TAST
225
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $20.5M | 0.06% |
1,676,138
+31,432
| +2% | +$411K |
|
Similar funds
QCM
Brown Advisory's Q2 2017 Portfolio in Review
As of Q2 2017, Brown Advisory held 1,273 positions worth $32.7B, up 12% from $29.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Brown Advisory deployed $2.02B of net new capital in Q2 2017, opening 114 new positions and adding to 570 existing holdings. Its largest new stake was Altaba Inc: 2,311,186 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $290M trimmed.
- Brown Advisory's largest Q2 2017 buy was Altaba Inc: 2,311,186 shares worth $126M.
- Brown Advisory added most to Zoetis in Q2 2017, an estimated $437M increase.
- Brown Advisory's biggest Q2 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $290M.
- Brown Advisory fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $264M.
- Brown Advisory's ten largest holdings make up 20% of its $32.7B portfolio in Q2 2017.
- Brown Advisory opened 114 new positions and closed 56 in Q2 2017.
- Brown Advisory's portfolio value rose 12% quarter-over-quarter to $32.7B.
Based on Brown Advisory's 13F filing for Q2 2017, filed 14 Aug 2017.